Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas
Authors:
Open Access
- 1 June 2002
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 72 (6) , 782-787
Abstract
Objective: To determine whether the expression of platelet derived growth factor α receptor (PDGFRα) in low grade astrocytomas and oligoastrocytomas is associated with survival. Methods: Formalin fixed and paraffin embedded tumour samples of 40 consecutive patients with supratentorial diffuse astrocytomas and oligoastrocytomas of WHO grade 2, resected between 1986 and 1993, were used for immunohistochemical staining. The fraction of tumour cells expressing PDGFRα protein was quantified and entered into univariate and multivariate survival analyses. Changes in PDGFα expression over time were analysed in seven patients in whom reoperations had been performed. Results: Patients with a relatively high fraction of PDGFRα expressing cells had a more favourable outcome in both univariate (p = 0.04) and multivariate analyses (p = 0.02). Expression of PDGFRα was greater in oligoastrocytomas than in astrocytomas (p = 0.05). In four reoperated patients with histologically confirmed malignant transformation, there was a marked decrease in the number of cells expressing the receptor. Conclusions: There is an association between high PDGFRα expression and long survival time in patients with grade 2 astrocytomas and oligoastrocytomas. The findings suggest that expression of the receptor may be a useful prognostic marker in such patients.Keywords
This publication has 25 references indexed in Scilit:
- Oligodendrocyte Population Dynamics and the Role of PDGF In VivoNeuron, 1998
- Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytomaJournal of Neurosurgery, 1998
- Platelet-derived Growth Factor and Its Receptor Expression in Human OligodendrogliomasNeurosurgery, 1998
- Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.Journal of Clinical Oncology, 1997
- Low-grade gliomas of chronic epilepsy: A distinct clinical and pathological entityJournal of Neuro-Oncology, 1997
- A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.1996
- Platelet‐derived growth factor in human gliomaGlia, 1995
- Low-Grade Astrocytomas May Arise from Different Astrocyte LineagesNeurosurgery, 1993
- The New WHO Classification of Brain TumoursBrain Pathology, 1993